Thompson Elizabeth H.Z. insider trades
Thompson Elizabeth H.Z. has filed 24 Form 4s with the SEC that we hold, for HZNP (EVP, Research & Development), IGMS (Director) and Acadia Pharmaceuticals INC (ACAD) (EVP, Head of Research & Dev). Across all of them we count 0 purchases worth $0 and 9 sales worth $2.8M reported on Form 4. In the last 12 months: 0 purchases ($0) and 3 sales ($506.4K). The largest single trade was a sale of 8,098 shares of HZNP worth $936.5K, dated 2022-04-18. The first filing on our record is dated 2021-07-02 and the latest 2026-07-31.
HZNP
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-08-05 | S, sale reported on Form 4 | 7,542 | $802.0K | 2021-08-06 |
| 2022-04-18 | S, sale reported on Form 4 | 8,098 | $936.5K | 2022-04-20 |
| 2022-07-07 | S, sale reported on Form 4 | 82 | $7.0K | 2022-07-11 |
| 2022-07-19 | S, sale reported on Form 4 | 82 | $7.0K | 2022-07-20 |
| 2022-07-19 | S, sale reported on Form 4 | 8 | $680 | 2022-07-20 |
| 2022-07-20 | S, sale reported on Form 4 | 5,917 | $502.9K | 2022-07-20 |
IGMS
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Acadia Pharmaceuticals INC (ACAD)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-03-25 | S, sale reported on Form 4 | 3,435 | $73.7K | 2026-03-26 |
| 2026-07-30 | S, sale reported on Form 4 | 16,508 | $431.4K | 2026-07-31 |
| 2026-07-30 | S, sale reported on Form 4 | 50 | $1.3K | 2026-07-31 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1861477) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms